OTCMKTS:ITHUF

iAnthus Capital Stock Forecast, Price & News

$0.19
-0.03 (-13.51 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.18
Now: $0.19
$0.23
50-Day Range
$0.21
MA: $0.27
$0.31
52-Week Range
$0.05
Now: $0.19
$0.52
Volume930,081 shs
Average Volume1.24 million shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
iAnthus Capital Holdings, Inc. owns and operates licensed cannabis cultivation, processing, and dispensary facilities in the United States. It offers biomass products, such as pre-rolls; cannabis infused products, including topical creams and edibles; vape cartridges, concentrates, live resins, wax products, oils, and tinctures; cannabidiol products, such as topical creams, tinctures, and sprays, as well as products for beauty and skincare that include lotions, creams, haircare products, lip balms, and bath bombs. The company engages in the wholesale-distribution and retail of CBD products. It owns and/or operates 31 dispensaries and 10 cultivation and/or processing facilities in 9 states. The company is headquartered in New York, New York.
iAnthus Capital logo

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:ITHUF
CUSIPN/A
CIKN/A
Phone646 518 9411
Employees890
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

iAnthus Capital (OTCMKTS:ITHUF) Trading Down 3.9%
April 13, 2021 |  americanbankingnews.com
iAnthus Announces Filing of Form 10 Registration Statement
December 8, 2020 |  finance.yahoo.com
Recent Trading Activity of iAnthus Stock
December 4, 2020 |  finance.yahoo.com
iAnthus Capital Holdings, Inc. (ITHUF)
November 1, 2020 |  finance.yahoo.com
IANTHUS CAPITAL HLDGS INC (2IA.MU)
October 11, 2020 |  in.finance.yahoo.com
Final Court Order Hearing
September 18, 2020 |  finance.yahoo.com
See More Headlines

MarketRank

Overall MarketRank

0.58 out of 5 stars

Medical Sector

1409th out of 2,024 stocks

Drug Manufacturers - Specialty & Generic Industry

31st out of 61 stocks

Analyst Opinion: 0.0Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
$0.19
-0.03 (-13.51 %)
(As of 04/19/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive ITHUF News and Ratings via Email

Sign-up to receive the latest news and ratings for ITHUF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











iAnthus Capital (OTCMKTS:ITHUF) Frequently Asked Questions

What stocks does MarketBeat like better than iAnthus Capital?

Wall Street analysts have given iAnthus Capital a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but iAnthus Capital wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How has iAnthus Capital's stock been impacted by Coronavirus (COVID-19)?

iAnthus Capital's stock was trading at $0.5282 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, ITHUF stock has decreased by 63.7% and is now trading at $0.1920.
View which stocks have been most impacted by COVID-19
.

Who are iAnthus Capital's key executives?

iAnthus Capital's management team includes the following people:
  • Mr. Randy Maslow, Co-Founder, Pres, MD, Interim CEO & Director (Age 65, Pay $675k)
  • Mr. Julius John Kalcevich, CFO & Corp. Sec. (Age 47, Pay $675k)
  • Mr. Robert R. Galvin, Sr. VP, Chief Admin. Officer & Interim COO (Age 60, Pay $7.15M)
  • Ms. Megan W. Kulick CFA, VP of Investor Relations
  • Mr. Andrew R. Ryan Esq., Gen. Counsel
  • Mr. Ethan F. Anderson, Sr. VP of Marketing (Age 49)
  • Dr. Richard J. Boxer, Chief Medical Officer
  • Mr. John Traylor Henderson, Sr. VP of Eastern Operations
  • Mr. Michael R. Woolston, Sr. VP of Manufacturing, Supply Chain & Quality

Who are some of iAnthus Capital's key competitors?

What is iAnthus Capital's stock symbol?

iAnthus Capital trades on the OTCMKTS under the ticker symbol "ITHUF."

How do I buy shares of iAnthus Capital?

Shares of ITHUF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is iAnthus Capital's stock price today?

One share of ITHUF stock can currently be purchased for approximately $0.19.

How many employees does iAnthus Capital have?

iAnthus Capital employs 890 workers across the globe.

What is iAnthus Capital's official website?

The official website for iAnthus Capital is www.ianthuscapital.com.

How can I contact iAnthus Capital?

The company can be reached via phone at 646 518 9411.


This page was last updated on 4/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.